Although no previous studies have linked immunomodulation in HD and the KP, several studies have reported that immune rescue in HD mouse models has therapeutic benefits32,33, thus immunosuppression via KMO inhibition may provide a potential therapeutic strategy for HD. Here, KMO is linked to Huntington disease.